# Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels

> **NCT04263571** · — · UNKNOWN · sponsor: **Goethe University** · enrollment: 100 (estimated)

## Conditions studied

- Anemia
- IV Iron

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04263571
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-12
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-10-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263571, "Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04263571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*